ConductScience.org, home

Trial · NCT00546754

Participant flow12

How many started, completed or left each group, period by period.

PeriodMilestoneGroupParticipantsUnits counted
Overall StudySTARTEDLosartan 50 mg/HCTZ 12.5 mg425
Overall StudySTARTEDValsartan 80 mg/HCTZ 12.5 mg383
Overall StudyTreatedLosartan 50 mg/HCTZ 12.5 mg416
Overall StudyTreatedValsartan 80 mg/HCTZ 12.5 mg373
Overall StudyWeek 6Losartan 50 mg/HCTZ 12.5 mg396
Overall StudyWeek 6Valsartan 80 mg/HCTZ 12.5 mg347
Overall StudyWeek 12Losartan 50 mg/HCTZ 12.5 mg375
Overall StudyWeek 12Valsartan 80 mg/HCTZ 12.5 mg334
Overall StudyCOMPLETEDLosartan 50 mg/HCTZ 12.5 mg375
Overall StudyCOMPLETEDValsartan 80 mg/HCTZ 12.5 mg334
Overall StudyNOT COMPLETEDLosartan 50 mg/HCTZ 12.5 mg50
Overall StudyNOT COMPLETEDValsartan 80 mg/HCTZ 12.5 mg49

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00546754/flow